APRI (AST to Platelet Ratio Index)
Assess likelihood of fibrosis or cirrhosis non-invasively using AST and platelet count.
About
The AST to Platelet Ratio Index (APRI) tool has been found to useful as a non-invasive index that correlates with liver biopsy findings of fibrosis and cirrhosis.
In a meta-analysis by Lin et al, it was found that in patients with hepatitis C, an APRI score greater than 1.0 had a sensitivity of 76% and specificity of 72% for predicting cirrhosis. In addition, it was found that an APRI score greater than 0.7 had a sensitivity of 77% and specificity of 72% for predicting significant hepatic fibrosis.
References
Lin ZH, Xin YN, Dong QJ, et al.
By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.